Insurance Broker

Marsh & McLennan Q4 Revenue Shows Decline in Profit

UPDATED ON
January 30, 2023
Abbey Dean
Abbey Dean
— Written By
Print Friendly and PDF

Marsh & McLennan Cos. Inc. recently announced the fourth quarter's combined revenue came to $5 billion, down 2% from the same time in 2021 but up 7% on an underlying basis.

Although the economy is facing the possibility of a recession, many elements continue to be favorable for the company's growth, according to Marsh McLennan President and CEO John Doyle.

Despite a slowdown in growth rates, Doyle said that commercial property/casualty insurance pricing will continue to rise on average “across many lines and geographies." Doyle also noted that the challenging reinsurance market may have an impact on other insurance rates, especially property insurance.

The brokerage is currently anticipating underlying growth for the year to be to be in the mid-single digits or higher.

To read the complete article, click here.

Looking for more exclusive content? See what’s trending on the Mployer Advisor blog.    


Want more insights on how your employee benefits compare to companies in your region, industry, and similar employer size?
Download Your Custom Benefits Report Now
See How Your Employee Benefits Compare

Next Up

Federal Court Ruling May Put Millions of US Companies In Breach of ERISA Fiduciary Duty
A Texas court ruled that American Airlines breached its ERISA duty of loyalty by failing to properly oversee BlackRock’s ESG-driven investment decisions. The decision could put millions of employers at legal risk if upheld. Are ESG investments in retirement plans now a liability?
The Employment Situation for February 2025
The latest economic release from the Bureau of Labor Statistics reports that the U.S. job market added just under 150 thousand jobs last month while unemployment ticked down one-tenth of a point to 4% to close out the last such economic report with data collected under the Biden administration.
Are Centers of Excellence On the Decline?
Centers of Excellence (COEs) may have peaked. While mid-sized employers increased adoption, the largest companies are scaling back. Is this a temporary dip or a shift in employer healthcare strategy?